To amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to establish requirements with respect to cost-sharing for certain insulin products, and for other purposes.

House Bill

H.R. 6255

119th Congress

To amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to establish requirements with respect to cost-sharing for certain insulin products, and for other purposes.

In Committee

Introduced:Nov 21, 2025

Primary Sponsor

Darren Soto

Representative

Democratic

FL-9

Cosponsors

0

Quick Stats

Policy Area

International Affairs

Summary

This bill would require health plans to cover certain insulin products and limit the amount people have to pay out-of-pocket for them. It aims to make insulin more affordable and accessible for people who need it to manage their diabetes.

Latest Action

Referred to the House Committee on Foreign Affairs.

AI Summary

Plain-English explanation of this bill

This bill would require health plans to cover certain insulin products and limit the amount people have to pay out-of-pocket for them. It aims to make insulin more affordable and accessible for people who need it to manage their diabetes.

Last updated: 12/29/2025

Official Summary

Congressional Research Service summary

<p>This bill requires the Department of State to submit a report to Congress concerning its Conflict and Stabilization Operations Bureau. </p><p>The report shall include, for example, (1) a bottom-line assessment as to whether the bureau should be maintained, (2) an analysis of costs associated with the bureau and potential cost savings related to dissolving the bureau, and (3) a plan detailing which functions or personnel would be absorbed by other elements in the State Department if the bureau is dissolved.</p>

Key Points

Main provisions of the bill

Health plans must cover at least one of each type and dosage form of insulin, such as rapid-acting, long-acting, etc.
Out-of-pocket costs for covered insulin products would be capped at either $35 per 30-day supply or 25% of the negotiated price, whichever is lower.
The cost-sharing limits would apply to in-network insulin products, but plans can impose higher costs for out-of-network insulin.

How This Impacts Americans

Potential effects on citizens and communities

This bill would directly benefit people with diabetes who rely on insulin to manage their condition. By capping out-of-pocket costs, it would make insulin more affordable and accessible, especially for those with high-deductible health plans or who are uninsured. This could improve health outcomes and reduce the financial burden of diabetes.

Policy Areas

Primary Policy Area

International Affairs

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

6255, 119th Congress (2025). "To amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to establish requirements with respect to cost-sharing for certain insulin products, and for other purposes.". Source: Voter's Right Platform. https://votersright.org/bills/118-hr-6255